Frontlight ResearchEarly access
CompletedNo phase
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose Challenge
Key facts
- Who runs it
- Methodist Health System
- Where
- Dallas, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 351 people enrolled
- Started
- 9 May 2023
- Ended
- 29 Mar 2024
- Type of study
- Observational
- Record updated
- 12 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Singleton pregnancies in which a 3-hour, 100-gram glucose test was completed and failed after 24-weeks' gestation
Who cannot take part
- Pregnancies with multiple gestations, glucose tests prior to 24 weeks', or those with incomplete 50-gram or 100-gram screening records
Where in United States
- Clinical Research Institute at Methodist Health SystemDallas, United States
About the trial
What the trial wants to find out
The aim of this study is to determine a 1-hour glucose tolerance test (GTT) value at which the diagnosis of gestational diabetes can be made without undergoing a 3-hour test.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 12 June 2026